Ligand Pharmaceuticals Inc (LGND)

Operating Expenses

$51.89M

Quarterly · Period ending: · USD

LGND logo

LGND Operating Expenses

Latest reported$51.89M
LGND Quarterly Operating Expenses ($2.00M → $51.89M)
High-resolution chart · PNG

LGND operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
51,888,000
32,279,000
65,614,500
35,710,000
36,276,000
76,700,000
49,612,000
36,174,000
75,957,000
16,922,000
29,795,000
26,305,000
26,680,000
26,057,000
-6,745,000
32,727,000
29,103,000
29,684,000
47,755,000
37,683,000
8,343,000
42,282,000
47,041,000
31,748,000
26,676,000
24,690,000
35,245,000
26,819,000
26,712,000
25,880,000
23,486,000
20,841,000
18,734,000
18,328,000
20,376,000
14,497,000
14,077,000
18,710,000
15,765,000
14,909,000
14,051,000
13,353,000
9,058,000
7,509,000
11,235,000
9,956,000
8,797,000
9,763,000
7,928,000
8,203,000
6,794,000
7,170,000
6,328,000
6,967,000
6,759,000
7,029,000
6,790,000
6,320,000
6,874,000
6,155,000
7,092,000
6,166,000
8,850,000
23,477,000
9,466,000
10,410,000
28,382,000
12,336,000
12,301,000
17,279,000
13,778,000
11,603,000
10,437,000
16,773,000
13,812,000
14,203,000
15,776,000
29,278,000
23,362,000
45,972,000
49,171,000
178,317,000
41,439,000
36,292,000
41,639,000
41,690,000
38,854,000
42,371,000
41,799,000
38,055,000
38,291,000
30,912,000
30,430,000
29,066,000
27,346,000
26,407,000
23,960,000
22,773,000
20,804,000
20,088,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.